Evaluation of Intravitreal Aflibercept Injection for Macular Edema Secondary to Retinal Vein Occlusion
نویسندگان
چکیده
منابع مشابه
Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
AIM To report the efficacy of intravitreal ziv-aflibercept injections in eyes with macular edema due to retinal vein occlusions (RVOs). METHODS Consecutive patients with persistent or recurrent macular edema (central macula thickness >250 μm) due to RVO were enrolled in this prospective study. Study eyes received intravitreal injections of ziv-aflibercept (1.25 mg/0.05 mL) at baseline. Patien...
متن کاملEvaluation of Contrast Sensitivity after Single Intravitreal Triamcinolone Injection for Macular Edema Secondary to Branch Retinal Vein Occlusion
Purpose. To evaluate visual acuity (VA), contrast sensitivity (CS), and central retinal thickness (CRT) after intravitreal triamcinolone acetonide (IVT) injection for macular edema secondary to branch retinal vein occlusion (BRVO). Methods. In this prospective study, a total of 21 eyes of 21 patients were included. VA, CS, and CRT were assessed at baseline and at 1, 3, and 6 months after a sing...
متن کاملMacular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion
It has been reported that microperimetry is effective for evaluating macular function. The aim of this paper is to report and discuss changes seen in macular sensitivity and macular thickness after intravitreal injection of triamcinolone acetonide (IVTA) in two patients with macular edema and central retinal vein occlusion (CRVO). Two eyes from two patients with CRVO (one each with ischemic and...
متن کاملIntravitreal Ranibizumab for Treatment of Macular Edema Secondary to Retinal Vein Occlusion
R etinal vein occlusion (RVO) is a common retinal vascular disease that can lead to significant visual loss and blindness. The 15year cumulative incidences of branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO) are 1.8% and 0.5%, respectively, thus representing a serious public health problem. The main risk factors for RVO include age, hypertension, arteriosclerosis, ...
متن کاملIntravitreal bevacizumab for macular edema secondary to branch retinal vein occlusion.
PURPOSE To evaluate the effect of intravitreal bevacizumab on the visual and anatomical outcome in eyes with macular edema secondary to branch retinal vein occlusion. METHODS A retrospective, consecutive case series identified 53 consecutive patients with a branch retinal vein occlusion treated with intravitreal bevacizumab. Clinical variables were analyzed, including best-corrected visual ac...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Egyptian Journal of Hospital Medicine
سال: 2019
ISSN: 2090-7125
DOI: 10.21608/ejhm.2019.22981